prolyl-phenylalanyl-n-heptylargininamide has been researched along with Pancreatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fareed, J; Hoppensteadt, D; Izquierdo, R; Nora, MO; Prinz, RA; Sandberg, L; Squillaci, G; Walenga, J | 1 |
| Fareed, J; Hoppensteadt, D; Izquierdo, R; Prinz, R; Sandberg, L; Squillaci, G; Walenga, J | 1 |
2 other study(ies) available for prolyl-phenylalanyl-n-heptylargininamide and Pancreatitis
| Article | Year |
|---|---|
Comparative study of protease inhibitors on coagulation abnormalities in canine pancreatitis.
Topics: Acute Disease; alpha 1-Antitrypsin; Animals; Aprotinin; Bile; Blood Coagulation Disorders; Dogs; Drug Evaluation, Preclinical; Fibrinolysis; Oligopeptides; Pancreatitis; Protease Inhibitors | 1984 |
Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis.
Topics: Acute Disease; alpha-2-Antiplasmin; Amylases; Animals; Antithrombin III; Aprotinin; Blood Coagulation; Disease Models, Animal; Dogs; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Oligopeptides; Pancreatitis; Peptide Fragments; Platelet Count; Protease Inhibitors; Prothrombin Time | 1984 |